International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
May 17, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research
May 08, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial
April 29, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results
April 15, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Commences Trading on the OTCQX Best Market
March 04, 2019 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
February 13, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business
January 15, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based, clinical stage...
International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018
November 15, 2018 08:30 ET
|
International Stem Cell Corporation
Increases in Revenues and Profit MarginsNet Income Realized for the Quarter CARLSBAD, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO)...
International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial
November 05, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based...
International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial
November 05, 2018 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...